James P. Young

9.4k total citations · 2 hit papers
44 papers, 7.1k citations indexed

About

James P. Young is a scholar working on Pharmacology, Neurology and Physiology. According to data from OpenAlex, James P. Young has authored 44 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 7 papers in Neurology and 6 papers in Physiology. Recurrent topics in James P. Young's work include Musculoskeletal pain and rehabilitation (7 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers) and Pain Mechanisms and Treatments (5 papers). James P. Young is often cited by papers focused on Musculoskeletal pain and rehabilitation (7 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers) and Pain Mechanisms and Treatments (5 papers). James P. Young collaborates with scholars based in United States, United Kingdom and Netherlands. James P. Young's co-authors include Linda LaMoreaux, John L. Werth, John T. Farrar, Uma Sharma, Susan Martin, Robert H. Dworkin, I. Jon Russell, Philip J. Mease, Leslie J. Crofford and U. Sharma and has published in prestigious journals such as Neurology, Pain and American Political Science Review.

In The Last Decade

James P. Young

40 papers receiving 6.8k citations

Hit Papers

Clinical importance of changes in chronic pain intensity ... 2001 2026 2009 2017 2001 2003 1000 2.0k 3.0k 4.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James P. Young United States 18 3.2k 1.9k 1.7k 1.3k 1.2k 44 7.1k
Jacques Fermanian France 38 2.3k 0.7× 2.2k 1.2× 869 0.5× 1.6k 1.2× 578 0.5× 67 7.0k
John L. Werth United States 14 2.2k 0.7× 1.0k 0.6× 915 0.5× 1.2k 0.9× 670 0.6× 29 5.4k
Milton Cohen Australia 34 2.8k 0.9× 1.6k 0.9× 1.4k 0.8× 632 0.5× 1.0k 0.9× 81 6.6k
Serge Perrot France 51 4.5k 1.4× 2.5k 1.3× 4.1k 2.4× 811 0.6× 1.2k 1.0× 254 9.4k
Ajay D. Wasan United States 56 4.1k 1.3× 2.6k 1.4× 1.8k 1.1× 893 0.7× 2.1k 1.8× 181 9.2k
Brent R. Collett United States 37 2.7k 0.8× 1.5k 0.8× 1.5k 0.9× 1.0k 0.8× 1.2k 1.0× 129 8.5k
Mira Meeus Belgium 62 6.3k 1.9× 2.7k 1.5× 4.4k 2.6× 1.7k 1.2× 1.9k 1.7× 317 11.7k
Robert N. Jamison United States 55 4.6k 1.4× 1.8k 1.0× 1.1k 0.6× 899 0.7× 1.4k 1.2× 207 9.7k
John McBeth United Kingdom 50 3.5k 1.1× 1.2k 0.6× 3.2k 1.9× 586 0.4× 683 0.6× 167 7.7k
Paul M. Peloso United States 55 6.8k 2.1× 760 0.4× 2.1k 1.2× 2.1k 1.6× 800 0.7× 156 12.5k

Countries citing papers authored by James P. Young

Since Specialization
Citations

This map shows the geographic impact of James P. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James P. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James P. Young more than expected).

Fields of papers citing papers by James P. Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James P. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James P. Young. The network helps show where James P. Young may publish in the future.

Co-authorship network of co-authors of James P. Young

This figure shows the co-authorship network connecting the top 25 collaborators of James P. Young. A scholar is included among the top collaborators of James P. Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James P. Young. James P. Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sobel, Rachel E., Daniel J. Lovell, Hermine I. Brunner, et al.. (2014). Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the phase 4 registry. Pediatric Rheumatology. 12(1). 29–29. 17 indexed citations
2.
Sharma, Uma, T. Griesing, Birol Emir, & James P. Young. (2010). Time to Onset of Neuropathic Pain Reduction: A Retrospective Analysis of Data From Nine Controlled Trials of Pregabalin for Painful Diabetic Peripheral Neuropathy and Postherpetic Neuralgia. American Journal of Therapeutics. 17(6). 577–585. 46 indexed citations
3.
Arnold, Lesley M., I. Jon Russell, Erdal Diri, et al.. (2008). A 14-week, Randomized, Double-Blinded, Placebo-Controlled Monotherapy Trial of Pregabalin in Patients With Fibromyalgia. Journal of Pain. 9(9). 792–805. 233 indexed citations
4.
Crofford, Leslie J., Philip J. Mease, Susan Lee Simpson, et al.. (2008). Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): A 6-month, double-blind, placebo-controlled trial with pregabalin. Pain. 136(3). 419–431. 180 indexed citations
5.
Tölle, Thomas R., et al.. (2007). Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: A randomized, double‐blind study. European Journal of Pain. 12(2). 203–213. 171 indexed citations
6.
Arnold, Lesley M., Leslie J. Crofford, Susan Martin, James P. Young, & Uma Sharma. (2007). The Effect of Anxiety and Depression on Improvements in Pain in a Randomized, Controlled Trial of Pregabalin for Treatment of Fibromyalgia. Pain Medicine. 8(8). 633–638. 65 indexed citations
7.
Crofford, Leslie J., Michael C. Rowbotham, Philip J. Mease, et al.. (2005). Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double‐blind, placebo‐controlled trial. Arthritis & Rheumatism. 52(4). 1264–1273. 487 indexed citations
8.
Young, James P.. (2004). Democracy’s Discontents. International Studies in Philosophy. 36(1). 281–282. 10 indexed citations
9.
Brower, Kirk J., et al.. (1994). Severity and Treatment of Alcohol Withdrawal in Elderly Versus Younger Patients. Alcoholism Clinical and Experimental Research. 18(1). 196–201. 75 indexed citations
10.
Young, James P.. (1992). The Evolution of Rights in Liberal Theory. International Studies in Philosophy. 24(1). 136–137. 31 indexed citations
11.
Brower, Kirk J., Frederic C. Blow, James P. Young, & Elizabeth Hill. (1991). Symptoms and correlates of anabolic‐androgenic steroid dependence. British Journal of Addiction. 86(6). 759–768. 180 indexed citations
12.
Young, James P.. (1990). Expanding State Initiation and Enforcement under Superfund. The University of Chicago Law Review. 57(3). 985–985. 2 indexed citations
13.
Young, James P.. (1989). Public Life and Late Capitalism. International Studies in Philosophy. 21(3). 124–125. 21 indexed citations
14.
Young, James P.. (1988). Liberalism and the Limits of Justice. International Studies in Philosophy. 20(3). 145–146. 10 indexed citations
15.
Weber, Robert J., et al.. (1987). A miniature GPS receiver. MiJo. 30. 81. 3 indexed citations
16.
Young, James P.. (1987). Contemporary Political Thinkers. International Studies in Philosophy. 19(1). 98–99. 1 indexed citations
17.
Young, James P.. (1986). Natural Right Theories. International Studies in Philosophy. 18(3). 104–105. 3 indexed citations
18.
Young, James P.. (1981). The Politics of Imperfection. International Studies in Philosophy. 13(1). 108–108. 2 indexed citations
19.
Young, James P.. (1981). Rousseau’s Political Philosophy. International Studies in Philosophy. 13(1). 93–94. 1 indexed citations
20.
Young, James P.. (1968). The politics of affluence : ideology in the United States since World War II. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026